Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells

Stem Cells

Volumn 25, Issue 6, 2007, Pages 1431-1438

  Song, Heesang ^a   Chang, Woochul ^a   Lim, Soyeon ^a   Seo, Hye Sun ^a   Chi, Young Shim ^a   Park, Sungha ^a   Yoo, Kyung Jong ^a   Kim, Byung Soo ^b   Min, Byoung Hyun ^c   Lee, Hakbae ^d   Jang, Yangsoo ^a   Chung, Namsik ^a   Hwang, Ki Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Ajou University   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

Adhesion; Integrin; Mesenchymal stem cell; Tissue transglutaminase

Indexed keywords

FOCAL ADHESION KINASE; INTEGRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL SPREADING; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FIBROBLAST; GENETIC ENGINEERING; GENETIC TRANSFECTION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; MALE; MESENCHYME CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; BONE MARROW CELLS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; GTP-BINDING PROTEINS; HEART; INTEGRINS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION; TRANSGLUTAMINASES;

RATTUS;

EID: 34547104819     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0467     Document Type: Article

References (35)

1. Minguell JJ, Erices A. Mesenchymal stem cells and the treatment of cardiac disease. Exp Biol Med 2006;231:39-49.
2. Makino S, Fukuda K, Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705.
3. Toma C, Pittenger MF, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-98.
4. Zhang M, Methot D, Poppa V et al. Cardiomyocyte grafting for cardiac repair. Graft cell death and anti-death strategies. J Mol Cell Cardiol 2001;33:907-921.
5. Meredith JE Jr, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993;4:953-961.
6. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:619-626.
7. Gartner S, Kaplan HS. Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A 1980;77:4756-4759.
8. Ingber DE. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 2002;91:877-887.
9. Matter ML, Ruoslahti EA. Signaling pathway from the alpha5beta1 and alpha (v) beta3 integrins that elevates bcl-2 transcription. J Biol Chem 2001;276:27757-27763.
10. Gaudry CA, Verderio E, Jones RA et al. Tissue transglutaminase is an important player at the surface of human endothelial cells: Evidence for its externalization and its colocalization with the beta (1) integrin. Exp Cell Res 1999;252:104-113.
11. Akimov SS, Krylov D, Fleischman LF et al. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 2000;148:825-838.
12. Watanabe E, Smith DM Jr, Delcarpio JB et al. Cardiomyocyte transplantation in a porcine myocardial infarction model. Cell Transplant 1998;7:239-246.
13. Miyahara Y, Nagaya N, Kataoka M et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-465.
14. Kraitchman DL, Tatsumi M, Gilson WD et al. Dynamic imaging of allogenic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005;112:1451-1461.
15. Kraitchman DL, Heldman AW, Atalar E et al. In vivo magnetic imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003;107:2290-2293.
16. Jones RA, Nicholas B, Mian S et al. Reduced expression of tissue transglutaminase in a human endothelial cell line leads to change in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci 1997;110:2461-2472.
17. Agah A, Kyriakides TR, Bornstein P. Proteolytic of cell-surface tissue transglutaminase by matrix metalloproteinase-2 contributes to the adhesive defect and matrix abnormalities in thrombospondin-2 null fibroblasts and mice. Am J Pathol 2005;167:81-88.
18. Cukierman E, Pankov R, Stevens DR. Taking cell-matrix adhesions to the third dimension. Science 2001;294:1708-1712.
19. Hwang KC, Gray CD, Sivasubramanian N et al. Interaction site of GTP binding Gh (Transglutaminase II) with phospholipase C. J Biol Chem 1995;270:27058-27062.
20. 2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes. Eur J Pharmacol 2006;535:212-219.
21. Langeland S, D'hooge J, Wouters PF et al. Experimental validation of a new ultrasound method for the simultaneous assessment of radial and longitudinal myocardial deformation independent of insonation angle. Circulation 2005;112:2157-2162.
22. Nagaya N, Kangawa K, Itoh T et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005;112:1128-1138.
23. Taylor DA, Atkins BZ, Hungspreugs P et al Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-933.
24. Reinecke H, Zhang M, Bartosek T et al. Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation 1999;100:193-202.
25. Lipsic E, van der Meer P, Henning RH et al. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion. J Cardiovasc Pharmacol 2004;44:473-479.
26. Murry CE, Wiseman RW, Schwartz SM et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512-2523.
27. Li RK, Mickle DA, Weisel RD et al. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation 1997;96(suppl 9):S179-S186.
28. Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-1201.
29. Wollert KC, Drexler H. Clinical application of stem cells for the heart. Circ Res 2005;96:151-163.
30. Kamihata H, Matsubara H, Nishiue T et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001;104:1046-1052.
31. Fuchs S, Baffour R, Zhou YF et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardium ischemia. J Am Coll Cardiol 2001;37:1726-1732.
32. Kinnaird T, Stabile E, Burnett MS et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004;94:678-685.
33. Guerette B, Skuk D, Celestin F et al. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J Immunol 1997;159:2522-2531.
34. Zvibel I, Smets F, Soriano H. Anoikis: Roadblock to cell transplantation. Cell Transplant 2002;11:621-630.
35. Thomas FT, Contreras JL, Bilbao G et al. Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. Surgery 1999;126:299-304.